1369773-39-6 Usage
Description
AHU-377 (heMicalciuM salt) is a chemical compound with specific properties that make it suitable for various applications across different industries. Its unique characteristics allow it to be utilized in a range of contexts, from pharmaceuticals to industrial processes.
Uses
Used in Pharmaceutical Industry:
AHU-377 (heMicalciuM salt) is used as an active pharmaceutical ingredient for its potential therapeutic effects. It may be employed in the development of new drugs or the enhancement of existing ones, contributing to improved patient outcomes.
Used in Chemical Industry:
In the chemical industry, AHU-377 (heMicalciuM salt) is used as a key component in the synthesis of various compounds. Its unique properties enable it to act as a catalyst or intermediate in chemical reactions, facilitating the production of desired products.
Used in Research and Development:
AHU-377 (heMicalciuM salt) is utilized as a research tool in the field of material science and biology. Its properties make it a valuable compound for studying the mechanisms of various biological processes and for developing new materials with specific characteristics.
Used in Drug Delivery Systems:
Similar to gallotannin, AHU-377 (heMicalciuM salt) can be employed in drug delivery systems to improve the bioavailability and therapeutic outcomes of certain medications. Its incorporation into novel drug delivery platforms may enhance the efficacy of drugs and reduce side effects.
Biochem/physiol Actions
Sacubitril (AHU377) is a prodrug inhibitor of the membrane metallo-endopeptidase neprilysin. Sacubitril forms half of the heart failure combination drug LCZ696, along with the angiotensin-receptor blocker Valsartan. Sacubitril (AHU377) is cojnverted by esterases into the active inhibitor LBQ657, which prevents neprilysin′s degradation of atrial and brain natriuretic peptide, two blood pressure lowering peptides. The AHU377 valsartan combination drug LCZ696 showed a reduction in the risk of cardiovascular death of 20% compared to the standard ACE inhibitor enalapril, and also a 21% drop in the risk of hospitalization.
Check Digit Verification of cas no
The CAS Registry Mumber 1369773-39-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,9,7,7 and 3 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1369773-39:
(9*1)+(8*3)+(7*6)+(6*9)+(5*7)+(4*7)+(3*3)+(2*3)+(1*9)=216
216 % 10 = 6
So 1369773-39-6 is a valid CAS Registry Number.